What is Evolent Health, Inc.'s SG&A?

Evolent Health, Inc. (EVH) reported SG&A of $72.82M in Q1 2026.

How has Evolent Health, Inc.'s SG&A changed year-over-year?

Evolent Health, Inc.'s SG&A decreased by 7.1% year-over-year, from $78.41M to $72.82M.

What is the long-term trend for Evolent Health, Inc.'s SG&A?

Over 4 years (2021 to 2025), Evolent Health, Inc.'s SG&A has grown at a 8.5% compound annual growth rate (CAGR), from $219.5M to $303.87M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Evolent Health, Inc. EVH SG&A

SG&A at other companies

UnitedHealth GroupUNH

$15.39B+13.2%

The Oncology Institute, Inc.TOI

$28.21M+11.2%

BrightSpring Health Services, Inc.BTSG

$360.77M+25.4%

Elevance HealthELV

$6.33B+19.4%

Alignment HealthcareALHC

$121.14M+16.7%

CencoraCOR

$1.98B+23.6%

Other financials

Income statement

See full

Revenue$496.2M+2.6%

Gross profit$83.8M-18.2%

Operating income-$10.6M-553%

Net income-$26.6M+58.8%

EPS (diluted)-$0.24+61.9%

Balance sheet

See full

Cash & equivalents$142.0M-42.4%

Total debt$985.4M+13.3%

Total equity$396.4M-57.6%

Total assets$1.9B-29.2%

Cash flow

See full

Operating cash flow-$984.0K-122%

Valuation

See full

Market cap$565.78M-47.9%

Enterprise value$1.41B-17.6%

P/S0.3×-0.2×

Profitability

See full

Gross margin20.2%+4.9pp

Operating margin-22.2%-23.5pp

Net margin-26.3%-33.2pp

FCF margin-9.7%—

Returns & leverage

See full

Return on equity-74.6%-90.1pp

Debt / equity2.5×+1.6×

Current ratio1.3×+0.3×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evolent Health, Inc.'s SG&A?: Evolent Health, Inc. (EVH) reported SG&A of $72.82M in Q1 2026.
How has Evolent Health, Inc.'s SG&A changed year-over-year?: Evolent Health, Inc.'s SG&A decreased by 7.1% year-over-year, from $78.41M to $72.82M.
What is the long-term trend for Evolent Health, Inc.'s SG&A?: Over 4 years (2021 to 2025), Evolent Health, Inc.'s SG&A has grown at a 8.5% compound annual growth rate (CAGR), from $219.5M to $303.87M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.